Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Placebo Controlled, Phase II Trial, on the Effect of an Oral Supplement,TK3 (Tryptophan and Thiamine) on the Quality of Life and Chemotherapy Tolerance in Cancer Patients With Advanced Disease.

NCT03341286 is registered in ClinicalTrials.gov with Faculdade de Medicina do ABC as lead sponsor.

NCT NCT03341286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03341286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Placebo Controlled, Phase II Trial, on the Effect of an Oral Supplement,TK3 (Tryptophan and Thiamine) on the Quality of Life and Chemotherapy Tolerance in Cancer Patients With Advanced Disease.
Lead sponsor
Faculdade de Medicina do ABC
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2017
Completion date
May 31, 2019
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, chemotherapy effect, quality of life, thiamine, tryptophan